Seems like Cowen’s HC and Biotech groups are killing it in deal flow. Anyone have any experience with them and have any thoughts on how they stack up against other groups in terms of deal flow/exit ops/culture?
| +228 | UBS Accused of Favoring H-1B Workers While Cutting U.S.-Born Employees | 55 | 8h |
| +134 | ONLY THESE BANKS OR YOU STRUCK OUT | 36 | 35m |
| +111 | IB Energy Drink Tier List / Ranking | 73 | 21h |
| +91 | PJT M&A Group Selection 2026 | 14 | 2d |
| +59 | Firm Thinks I'm Lying About Offer | 18 | 1d |
| +51 | Feedback for internship first desk at IBD BB - personal fit, "don't be too confident" | 29 | 2d |
| +44 | Indiana University Fraternity Pipelines | 29 | 33m |
| +39 | Stay at Weak Dealflow Team or Lateral? | 12 | 3h |
| +32 | Rogo AI | 12 | 3h |
| +31 | Elite Boutique interview questions | 8 | 5h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Hi tgn005, check out these links:
I hope those threads give you a bit more insight.
bump. Any opinions would be helpful especially regarding exit ops.
Mollitia quos nulla nesciunt dignissimos voluptatem sunt. Illum earum perspiciatis sed. Sed officiis esse harum omnis et quo. Natus quod quia iste eos et. Id modi amet animi ipsum excepturi quo. Delectus dolorem modi expedita eum officiis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...